Boji Medicine has obtained the invention patent for the "method of determining the content of berberine in berberine with tannic acid".

Recently, Boji Pharmaceutical Technology Co., Ltd. was granted an invention patent certificate by the National Intellectual Property Office. The patent is titled "A method for determining gallic acid in berberine", with certificate number 8272934, patent number ZL202510318197.1, application date of March 18, 2025, and authorization announcement date of September 19, 2025. This method involves the field of drug ingredient detection, which can achieve good separation of gallic acid, berberine, and ellagic acid, with short detection time and high separation degree. Although this patent has no significant impact on the company's operating performance, it benefits the company's technological innovation, improves the intellectual property protection system, and enhances core competitiveness.